GLYCAN THERAPEUTICS CORPORATION — SBIR/STTR Competitive Profile
Aggregate SBIR/STTR award history for GLYCAN THERAPEUTICS CORPORATION, built entirely from public federal award records. Free competitive intelligence — no login required.
- 18 awards
- $12,713,781 total on record
- 1 agency
- 13 Phase I · 5 Phase II
Phase mix
- Phase I — 13 awards
- Phase II — 5 awards
Funding agencies
Awards by year
- 2023 — 6 awards
- 2022 — 2 awards
- 2021 — 2 awards
- 2020 — 1 award
- 2019 — 2 awards
- 2018 — 1 award
- 2017 — 2 awards
Places of performance
Firms like GLYCAN THERAPEUTICS CORPORATION
See the companies with the most overlapping technology domains and funding agencies, ranked by a weighted-overlap similarity score.
Sign in to see firms like this
The full similar-firms list is free with an account. Sign in or create a free account to compare competitors.
Recent awards
| Award | Agency | Amount | Program | Start |
|---|---|---|---|---|
| 1R44GM145004-01A1 | Department of Health and Human Services | $255,001 | SBIR · Phase I | 2023-09-21 |
| 2R44GM144019-02 | Department of Health and Human Services | $874,308 | SBIR · Phase II | 2023-09-06 |
| 1R41DE032276-01A1 | Department of Health and Human Services | $347,537 | STTR · Phase I | 2023-09-01 |
| 1R44GM148100-01A1 | Department of Health and Human Services | $355,989 | SBIR · Phase I | 2023-08-16 |
| 1R41CA285005-01 | Department of Health and Human Services | $400,000 | STTR · Phase I | 2023-07-01 |
| 1R43GM149008-01 | Department of Health and Human Services | $350,000 | SBIR · Phase I | 2023-02-01 |
| 2R44GM142304-02 | Department of Health and Human Services | $1,977,542 | SBIR · Phase II | 2022-09-17 |
| 1R43GM140693-01A1 | Department of Health and Human Services | $331,634 | SBIR · Phase I | 2022-05-01 |
| 1R43GM142304-01 | Department of Health and Human Services | $300,000 | SBIR · Phase I | 2021-09-15 |
| 1R43GM144019-01 | Department of Health and Human Services | $231,139 | SBIR · Phase I | 2021-09-14 |
| 2R44GM123792-03 | Department of Health and Human Services | $2,411,727 | SBIR · Phase II | 2020-05-01 |
| 1R44GM134738-01 | Department of Health and Human Services | $536,791 | SBIR · Phase I | 2019-08-01 |
Frequently asked questions
How many SBIR/STTR awards has GLYCAN THERAPEUTICS CORPORATION won?
GLYCAN THERAPEUTICS CORPORATION has won 18 SBIR/STTR awards worth $12,713,781 in the public federal award records SBIR Signal tracks, including 13 Phase I and 5 Phase II award(s).
Which agencies fund GLYCAN THERAPEUTICS CORPORATION?
GLYCAN THERAPEUTICS CORPORATION's awards come from 1 agency on record; its top funder is Department of Health and Human Services.
What technology areas does GLYCAN THERAPEUTICS CORPORATION work in?
Based on its award history, GLYCAN THERAPEUTICS CORPORATION works in a range of technology areas.
How do I find firms similar to GLYCAN THERAPEUTICS CORPORATION?
Sign in and open the 'firms like this' view on the profile to see the companies with the most overlapping technology domains and funding agencies.